Skip to main content
. Author manuscript; available in PMC: 2015 Oct 13.
Published in final edited form as: Nat Rev Cancer. 2010 Jul;10(7):470–480. doi: 10.1038/nrc2877

Figure 1. Conditional genetically engineered mouse models (GEMMs).

Figure 1

a | Activating Cre in a tissue-specific manner, by either viral delivery or Cre-oestrogen response element (ERE)-mediated tamoxifen administration. Examples are shown for lung cancer7 and ovarian cancer12, and melanoma11. b | Tetracycline (Tet)-mediated transgene inactivation or activation by doxycycline administration or withdrawal using the Tet-On or Tet-Off systems. Examples are shown for liver cancer22 and melanoma5. fl, flox; lsl, lox-STOP-lox; rtTA, reverse transactivator; tTA, transactivator.